RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
BioNexus Gene Lab Stock

BioNexus Gene Lab ROCE 2025

BioNexus Gene Lab ROCE

-0.2

Ticker

BGLC

ISIN

US0906283066

In 2025, BioNexus Gene Lab's return on capital employed (ROCE) was -0.2, a -24.76% increase from the -0.27 ROCE in the previous year.

BioNexus Gene Lab Aktienanalyse

What does BioNexus Gene Lab do?

BioNexus Gene Lab ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling BioNexus Gene Lab's Return on Capital Employed (ROCE)

BioNexus Gene Lab's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing BioNexus Gene Lab's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

BioNexus Gene Lab's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in BioNexus Gene Lab’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about BioNexus Gene Lab stock

What is the ROCE (Return on Capital Employed) of BioNexus Gene Lab this year?

The ROCE of BioNexus Gene Lab is -0.2 undefined this year.

How has the ROCE (Return on Capital Employed) of BioNexus Gene Lab developed compared to the previous year?

The ROCE of BioNexus Gene Lab has increased by -24.76% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of BioNexus Gene Lab?

A high Return on Capital Employed (ROCE) indicates that BioNexus Gene Lab has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of BioNexus Gene Lab?

A low ROCE (Return on Capital Employed) can indicate that BioNexus Gene Lab has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from BioNexus Gene Lab impact the company?

An increase in the ROCE of BioNexus Gene Lab can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of BioNexus Gene Lab affect the company?

A decrease in ROCE of BioNexus Gene Lab can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of BioNexus Gene Lab?

Some factors that can affect BioNexus Gene Lab's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of BioNexus Gene Lab so important for investors?

The ROCE of BioNexus Gene Lab is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can BioNexus Gene Lab take to improve the ROCE?

To improve the ROCE, BioNexus Gene Lab can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does BioNexus Gene Lab pay?

Over the past 12 months, BioNexus Gene Lab paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, BioNexus Gene Lab is expected to pay a dividend of 0 USD.

What is the dividend yield of BioNexus Gene Lab?

The current dividend yield of BioNexus Gene Lab is .

When does BioNexus Gene Lab pay dividends?

BioNexus Gene Lab pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of BioNexus Gene Lab?

BioNexus Gene Lab paid dividends every year for the past 0 years.

What is the dividend of BioNexus Gene Lab?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is BioNexus Gene Lab located?

BioNexus Gene Lab is assigned to the '-' sector.

Wann musste ich die Aktien von BioNexus Gene Lab kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of BioNexus Gene Lab from 9/20/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/20/2025.

When did BioNexus Gene Lab pay the last dividend?

The last dividend was paid out on 9/20/2025.

What was the dividend of BioNexus Gene Lab in the year 2024?

In the year 2024, BioNexus Gene Lab distributed 0 USD as dividends.

In which currency does BioNexus Gene Lab pay out the dividend?

The dividends of BioNexus Gene Lab are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von BioNexus Gene Lab

Our stock analysis for BioNexus Gene Lab Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BioNexus Gene Lab Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.